AIZ
Assurant, Inc.
NYSEUSDEQUITY
Financial Services
DELAYED
Last price
284.04
▲ 2.04 (0.72%)
MARKET · —
Price
Open
282.00
Prev close
282.00
Day high
285.25
Day low
282.92
Volume
236.04K
Market cap
$14.01B
P/E (TTM)
13.60
52W range
205.01 – 303.94
Trailing performance
Returnvs SPY
1W
+0.59%
+2.0%
1M
+3.74%
+0.0%
3M
+11.08%
+8.0%
6M
+26.63%
+15.6%
YTD
+17.93%
+5.6%
1Y
+31.87%
+11.9%
3Y
+100.35%
+26.2%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap$14.01B
Enterprise value$14.18B
Revenue (TTM)$13.46B
Gross profit$1.79B
EBITDA$1.74B
Net income$1.05B
EPS (TTM)$20.88
Free cash flow$2.15B
Total cash$2.03B
Total debt$2.21B
Book value / share$123.48
Shares outstanding49.32M
Float48.95M
Short % of float3.24%
Dividend yield1.24%
Beta (5Y)0.54
Valuation & profitability ratios
Trailing P/E13.60
Forward P/E12.18
PEG ratio2.16
Price / sales—
Price / book2.30
EV / revenue1.05
EV / EBITDA8.17
Gross margin13.27%
Operating margin11.73%
Profit margin7.90%
Return on equity18.34%
Return on assets2.56%
Debt / equity36.21
Current ratio0.38
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total revenue | $12.81B | $11.88B | $11.13B | $10.19B |
| Cost of revenue | $0 | $0 | $0 | $0 |
| Gross profit | $0 | $0 | $0 | $0 |
| R&D | — | — | — | — |
| SG&A | — | — | — | — |
| Operating income | — | — | — | — |
| Pre-tax income | — | — | — | — |
| Tax provision | $0 | $0 | $0 | $0 |
| Net income | $872.70M | $760.20M | $642.50M | $276.60M |
| EBIT | $0 | $0 | $0 | $0 |
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Cash & equivalents | — | — | — | — |
| Short-term investments | — | — | — | — |
| Net receivables | — | — | — | — |
| Inventory | — | — | — | — |
| Total current assets | — | — | — | — |
| Total assets | — | — | — | — |
| Total current liabilities | — | — | — | — |
| Long-term debt | — | — | — | — |
| Total liabilities | — | — | — | — |
| Retained earnings | — | — | — | — |
| Shareholder equity | — | — | — | — |
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | $872.70M | $760.20M | $642.50M | $276.60M |
| Depreciation | — | — | — | — |
| Change in working capital | — | — | — | — |
| Operating cash flow | — | — | — | — |
| Capital expenditure | — | — | — | — |
| Investing cash flow | — | — | — | — |
| Dividends paid | — | — | — | — |
| Buybacks | — | — | — | — |
| Financing cash flow | — | — | — | — |
| Net change in cash | — | — | — | — |
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 5.18 | 6.41 | +23.7% |
| Mar 2026 | 5.33 | 5.95 | +11.7% |
| Dec 2025 | 5.50 | 5.61 | +1.9% |
| Sep 2025 | 4.28 | 5.73 | +34.0% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 4.47 | 7 | $3.46B | +7.0% |
| Next quarter | 5.41 | 7 | $3.54B | +5.6% |
| Current year | 22.20 | 6 | $13.87B | +8.2% |
| Next year | 23.32 | 7 | $14.65B | +5.7% |
Analyst targets & ownership
Mean target$322.33
High target$355.00
Low target$274.00
Implied upside13.48%
Analyst count6
ConsensusSTRONG BUY
Strong buy / Buy3 / 4
Hold0
Sell / Strong sell0 / 0
Held by insiders0.71%
Held by institutions99.89%
Institutions holding865
Price targets, consensus spread, insider and institutional ownership.
Insider net activity
Net shares
+156.79K
Net buying
Buy transactions
19
199.37K shares
Sell transactions
7
42.58K shares
Net transactions
+26
Buys less sells
Sell : buy shares
0.2 : 1
Mixed
Insider-held shares
349.21K
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Aug 6, 26 | NAIR BIJU Divisional Officer |
SELL | 3.93K | $1.19M | Direct |
| Jun 22, 26 | LONERGAN ROBERT ANTHONY Officer |
SELL | 7.00K | $1.84M | Direct |
| May 26, 26 | DIRIENZO DIMITRY Officer |
SELL | 2.00K | $511.36K | Direct |
| May 22, 26 | GRANAT SARI BETH Director |
STOCK | 668 | $0 | Direct |
| May 22, 26 | WARREN KEVIN M Director |
STOCK | 668 | $0 | Direct |
| May 22, 26 | REDZIC OGNJEN Director |
STOCK | 668 | $0 | Direct |
| May 22, 26 | BLAKE LYNN S. Director |
STOCK | 668 | $0 | Direct |
| May 22, 26 | BASU RAJIV Director |
STOCK | 668 | $0 | Direct |
| May 22, 26 | CARTER J BRAXTON II Director |
STOCK | 668 | $0 | Direct |
| May 22, 26 | REILLY PAUL J Director |
STOCK | 668 | $0 | Direct |
| May 22, 26 | EDELMAN HARRIET Director |
STOCK | 668 | $0 | Direct |
| May 22, 26 | ROSEN ELAINE DEBRA Director |
STOCK | 668 | $0 | Direct |
| May 15, 26 | MEIER KEITH Chief Financial Officer |
SELL | 25.00K | $6.36M | Direct |
| May 14, 26 | ROSENBLUM JAY E. Officer |
SELL | 2.00K | $503.54K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
CAMPBELL MICHAEL P |
Chief Operating Officer | 27.44K | Stock Award(Grant) |
DEMMINGS KEITH |
Chief Executive Officer | 136.63K | Stock Award(Grant) |
LONERGAN ROBERT ANTHONY |
Officer | 27.37K | Sale |
LUMSDEN RYAN |
Officer | 17.86K | Stock Award(Grant) |
LUTHI-PREVITALI FRANCESCA L. |
Chief Operating Officer | 16.02K | Stock Award(Grant) |
MEIER KEITH |
Chief Financial Officer | 19.40K | Sale |
NAIR BIJU |
Divisional Officer | 24.25K | Sale |
REILLY PAUL J |
Director | 22.16K | Stock Award(Grant) |
ROSEN ELAINE DEBRA |
Director | 27.69K | Stock Award(Grant) |
ROSENBLUM JAY E. |
Officer | 12.76K | Sale |
Moving averages & technicals
SMA 10
281.86
+0.77% from price
SMA 20
283.62
+0.15% from price
SMA 50
275.87
+2.96% from price
SMA 100
256.98
+10.53% from price
SMA 200
242.73
+17.02% from price
EMA 12
282.40
+0.58% from price
EMA 26
280.71
+1.18% from price
EMA 50
274.44
+3.50% from price
RSI (14)
54.8
Neutral
MACD (12,26,9)
1.69
Hist -1.05
ATR (14)
7.88
2.77% of price
Realised vol 30D
25.8%
Annualised
Bollinger upper
295.32
20, 2σ
Bollinger lower
271.92
20, 2σ
50 / 200 cross
Golden
275.87 vs 242.73
Trend bias
Above 200
+17.02%
Risk profile
Beta vs SPY
0.17
Less volatile than market
Correlation to SPY
0.10
Largely independent
Realised vol 30D
25.8%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-12.9%
Peak to trough
Max drawdown 5Y
-45.7%
Peak to trough
ATR 14
7.88
2.77% of price
Beta (reported)
0.54
5Y monthly, from filing
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Options analytics
Put / call volume
0.69
Call-heavy session
Put / call open interest
0.22
Positioning, not flow
Max pain
220.00
-22.5% from spot
ATM implied vol
24.4%
Nearest strike to spot
Skew (10% OTM)
+1.6%
Puts bid over calls
Call volume
26
Contracts, this expiry
Put volume
18
Contracts, this expiry
Heaviest call OI
290.00
183 contracts
Heaviest put OI
210.00
49 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Headlines
How Assurant’s Dividend Hike And Earnings Upgrade At Assurant (AIZ) Has Changed Its Investment Story
Simply Wall St. · 1h ago
3 Insurance Stocks That Concern Us
StockStory · 1d ago
Assurant (AIZ) Upgraded to Buy: What Does It Mean for the Stock?
Zacks · 2d ago
Is Agri Bank China (ACGBY) Stock Outpacing Its Finance Peers This Year?
Zacks · 2d ago
Should Value Investors Buy Assurant (AIZ) Stock?
Zacks · 2d ago
Morgan Stanley Adjusts Price Target on Assurant to $320 From $300, Keeps Overweight Rating
MT Newswires · 3d ago
3 Reasons to Avoid AIZ and 1 Stock to Buy Instead
StockStory · 4d ago
Q2 Earnings Outperformers: Assurant (NYSE:AIZ) And The Rest Of The Property & Casualty Insurance Stocks
StockStory · 7d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.